Centogene NV Return on Equity

Centogene NV (CNTG) currently reports a ROE of 127.65%. That is above the Healthcare sector average of 22.76%. Use the charts on this page to explore Centogene NV's ROE history and peer comparisons.

Centogene NV's ROE of 127.65% is higher than the Healthcare sector average of 22.76%. That is roughly 460.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Centogene NV's current 127.65% should be judged against Healthcare norms (sector average: 22.76%) and against CNTG's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 127.65%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.76%. From there, open related valuation or income-statement pages for Centogene NV, and consider following CNTG for alerts when major investors trade the stock.

Centogene NV is classified in the Healthcare sector. On ROE, it currently shows 127.65% versus a sector average near 22.76%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNTG with unrelated industries.